Application
B4GALT5 Antibody (C-term) western blot analysis in mouse heart tissue lysates (35ug/lane).This demonstrates the B4GALT5 antibody detected B4GALT5 protein (arrow).Application
B4GALT5 Antibody (C-term) flow cytometric analysis of WiDr cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | B4GALT5 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | B4GALT5 Beta-1 4-galactosyltransferase 5 Beta-1 4-GalT II UDP-Gal:beta-GlcNAc beta-1 4-galactosyltransferase 5 UDP-galactose:beta-N-acetylglucosamine beta-1 4-galactosyltransferase 5 |
|---|---|
| Molecular Weight(MW) | 45119 Da |
| Function | Responsible for the synthesis of complex-type N-linked oligosaccharides in many glycoproteins as well as the carbohydrate moieties of glycolipids |
| Tissue Specificity | Ubiquitously expressed. |
| Cellular Localization | Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein. Note=Trans cisternae of Golgi stack |
| Entrez Gene | 9334 |
|---|---|
| Nucleotide Accession | NP_004767.1 |
Application
B4GALT5 Antibody (C-term) western blot analysis in mouse heart tissue lysates (35ug/lane).This demonstrates the B4GALT5 antibody detected B4GALT5 protein (arrow).
Application
B4GALT5 Antibody (C-term) flow cytometric analysis of WiDr cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
